8-K - Processa Pharmaceuticals, Inc. | StockGist

Current Report Details

Event Type

Securities Modification

Charter Amendment

Exhibits

Disclosure

Mandatory

Variant

8-K

Items Reported

3.03

Material Modification to Rights of Security Holders To the extent required by Item 3.03 of Form 8-K, the information contained in Item 5.03 of this Current Repo

Securities Modification

5.03

Amendments to articles of incorporation or bylaws; change in fiscal year On December 12, 2025, Processa Pharmaceuticals, Inc. (the “Company”) filed with the Sec

Charter Amendment

9.01

Financial Statements and Exhibits (d) Exhibits Exhibit Description 3.1 Certificate of Amendment to the Fourth Amended and Restated Certificate of Incorporation

Exhibits Only

Exhibits (2)

3.1

EX-3.1

8-K